Cme (CME) Share-based Compensation (2010 - 2026)

Cme (CME) has reported Share-based Compensation for 17 consecutive years, with $119.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Share-based Compensation rose 479.23% year-over-year to $119.9 million in Q2 2026; TTM through Jun 2026 was $194.8 million, a 118.14% increase from a year earlier, with the FY2025 full-year figure at $94.8 million, up 5.92% from the prior year.
• Share-based Compensation was $119.9 million for Q2 2026 at Cme, up from $22.0 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $176.2 million in Q4 2025 and troughed at -$123.3 million in Q3 2025.
• A 5-year average of $8.2 million and a median of $20.1 million in 2022 frame the typical range for Share-based Compensation.
• The widest YoY moves for Share-based Compensation: up 550.18% in 2025, down 707.39% in 2025.
• Over 5 years, Share-based Compensation stood at -$10.3 million in 2022, then sank by 224.27% to -$33.4 million in 2023, then soared by 181.14% to $27.1 million in 2024, then soared by 550.18% to $176.2 million in 2025, then plunged by 31.95% to $119.9 million in 2026.
• The last three Share-based Compensation figures came in at $119.9 million (Q2 2026), $22.0 million (Q1 2026), and $176.2 million (Q4 2025), per Business Quant data.